Allison A. Campbell | |
---|---|
Born | 1963 Portland, Oregon |
Residence | U.S. |
Nationality | American |
Fields | Chemistry |
Institutions | Pacific Northwest National Laboratory |
Alma mater | Gettysburg College, State University of New York at Buffalo |
Website http://www.pnnl.gov/about/bio/AllisonCampbell.asp |
Allison A. Campbell (born 1963, Portland, Oregon) is an American chemist who is known in the areas of biomineralization, biomimetics and biomaterials for her innovative work on bioactive coatings for medical implants. She is the acting associate laboratory director for the Earth and Biological Sciences Directorate at the Pacific Northwest National Laboratory (PNNL) of the Department of Energy. She previously served as director of the Environmental Molecular Sciences Laboratory (EMSL) at PNNL. She was elected as the 2017 president of the American Chemical Society (ACS).
Campbell grew up in Portland, Oregon in a medical family: her father was a pediatric surgeon and her mother a medical technician. Campbell received a Bachelor of Arts degree in chemistry from Gettysburg College in Pennsylvania in 1985. She then attended the State University of New York at Buffalo, working with George Nancollas to study biomineralization and the interaction of proteins with minerals at the molecular level. She defended her thesis in 1990 and received her doctorate in physical chemistry from the University of Buffalo in 1991.
In 1990 Campbell began a postdoctoral fellowship in the material sciences department of the Pacific Northwest National Laboratory (PNNL) in Richland, Washington. In 1992 she joined their staff as a research scientist. She applied techniques for growing thin films on surfaces to the development of bioactive coatings. Campbell's bioceramics promote the growth of a calcium phosphate layer over implant surfaces for artificial hip and knee implants, dental implants, and pins supporting broken bones, to prevent wear and prolong implant usability. Campbell holds several patents for this new technology. The coating also kills bacteria, reducing post-surgical infections. The process was licensed to Bacterin in 2004. Campbell's work was recognized with several awards.